Blog
RSS FeedPosted by Michael Wonder on 30 Jul 2016
Controversial CDF revamp launches
29 July 2016 - England's Cancer Drugs Fund reopens under its new model today, but the pharma industry and charities are ...
Posted by Michael Wonder on 28 Jul 2016
Betting on hepatitis C: how financial speculation in drug development influences access to medicines
27 July 2016 - Victor Roy and Lawrence King argue that the acquisition strategies of drug companies magnify development costs and ...
Posted by Michael Wonder on 28 Jul 2016
NHS 'abandoning' thousands by rationing hepatitis C drugs
28 July 2016 - Addaction says NHS England decision to treat just 10,000 people a year with costly drugs is ‘potential ...
Posted by Michael Wonder on 28 Jul 2016
Sigma backs Productivity Commission’s federal pharmacy review
28 July 2016 - Sigma Pharmaceuticals has backed a federal government-sanctioned review into the sector, saying it is timely to take ...
Posted by Michael Wonder on 28 Jul 2016
Pharmacist conflicts of interest and 'up-selling' patients flagged in major federal government review
28 July 2016 - Pharmacists could see their PBS funding cut if they don't limit the space they devote to retail ...
Posted by Michael Wonder on 28 Jul 2016
PHARMAC confirms chickenpox vaccine for all kids
28 July 2016 - PHARMAC has confirmed it will extend funding for a chickenpox vaccine to all children and make an ...
Posted by Michael Wonder on 28 Jul 2016
Over 100,000 people set to benefit from PHARMAC vaccines decisions
28 July 2016 - PHARMAC has today announced changes to funded vaccines, which will benefit an extra 100,000 people. ...
Posted by Michael Wonder on 28 Jul 2016
October 2016 price disclosure cycle - indicative prices
28 July 2016 - Indicative 1 October 2016 prices resulting from the 2016 October cycle of price disclosure have now been ...
Posted by Michael Wonder on 27 Jul 2016
CADTH calls for patient input on submission from Pierre Fabre for Hemangiol (propranolol hydrochloride)
27 July 2016 - CADTH has received notice of a pending submission from Pierre Fabre for Hemangiol (propranolol hydrochloride). ...
Posted by Michael Wonder on 27 Jul 2016
Vertex seeks deal after NICE rejects CF drug Orkambi
27 July 2016 - NICE has rejected Vertex’s cystic fibrosis drug, Orkambi (lumacaftor+ivacaftor) for routine funding on the National Health Service ...
Posted by Michael Wonder on 27 Jul 2016
Shire and BMS secure NICE recommendations for oncology drugs
27 July 2016 - NICE has issued final guidance recommending Shire’s Oncaspar (pegaspargase) and Bristol-Myers Squibb’s Opdivo (nivolumab) plus Yervoy (ipilimumab) ...
Posted by Michael Wonder on 27 Jul 2016
NICE publishes final guidance on the use of nivolumab in combination with ipilimumab for treating advanced melanoma
27 July 2016 - NICE publishes further guidance on the use of nivolumab (Opdivo) in patients wth melanoma. ...
Posted by Michael Wonder on 27 Jul 2016
Ensuring Australians get most from community pharmacy
27 July 2016 - The Australian Government is ensuring Australians get the best experience possible from community pharmacy and wants to ...
Posted by Michael Wonder on 27 Jul 2016
Review process is an opportunity for pharmacy
27 July 2016 - The release of the discussion paper of the Review of Pharmacy Remuneration and Regulation is an important ...
Posted by Michael Wonder on 27 Jul 2016
Review of pharmacy remuneration and regulation - release of discussion paper
27 July 2016 - The Chair of the Review Panel, Professor Stephen King has announced the release of the review's discussion ...